Granuloma annulare associated with immune checkpoint inhibitors

J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e124-e126. doi: 10.1111/jdv.14617. Epub 2017 Oct 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Female
  • Granuloma Annulare / chemically induced*
  • Humans
  • Immunologic Factors / adverse effects*
  • Male
  • Nivolumab / adverse effects
  • Nivolumab / therapeutic use*

Substances

  • Antineoplastic Agents, Immunological
  • Immunologic Factors
  • Nivolumab